ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 33 filers reported holding ACORDA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $0 | – | 23,496 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 23,496 | -0.0% | 0.00% | – |
Q2 2020 | $0 | – | 23,497 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 23,497 | -97.7% | 0.00% | – |
Q4 2019 | $21,000 | -22.2% | 1,000,000 | 0.0% | 0.00% | – |
Q3 2019 | $27,000 | – | 1,000,000 | -90.0% | 0.00% | – |
Q2 2019 | $0 | – | 10,000,000 | +3497.1% | 0.00% | – |
Q1 2019 | $0 | – | 278,000 | -93.1% | 0.00% | – |
Q4 2018 | $0 | – | 4,028,000 | +64.6% | 0.00% | – |
Q3 2018 | $0 | – | 2,447,000 | +333.9% | 0.00% | – |
Q2 2018 | $0 | -100.0% | 564,000 | -9.8% | 0.00% | -100.0% |
Q2 2017 | $536,000 | -29.5% | 625,000 | -37.5% | 0.00% | -50.0% |
Q4 2016 | $760,000 | +223.4% | 1,000,000 | +277.4% | 0.00% | +100.0% |
Q1 2016 | $235,000 | -23.0% | 265,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $305,000 | -81.7% | 265,000 | -83.5% | 0.00% | -80.0% |
Q3 2014 | $1,663,000 | – | 1,603,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYMPHONY ASSET MANAGEMENT LLC | 23,872,000 | $18,748,000 | 4.04% |
PFM Health Sciences, LP | 49,764,825 | $39,319,000 | 1.16% |
Partner Investment Management, L.P. | 659,175 | $521,000 | 0.89% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000,000 | $31,402,000,000 | 0.87% |
Bruce & Co., Inc. | 6,000,000 | $4,200,000 | 0.87% |
CANYON CAPITAL ADVISORS LLC | 36,500,000 | $28,747,000 | 0.62% |
PenderFund Capital Management Ltd. | 2,000,000 | $1,571,000 | 0.53% |
Shaolin Capital Management LLC | 4,000,000 | $3,136,000 | 0.48% |
Castle Creek Arbitrage, LLC | 2,310,000 | $1,815,000 | 0.46% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $4,368,000 | 0.27% |